Resources

1 Resources for

rxcomms

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

AZ Seroquel Trial: Was It "Ghostwriting" or "Professional" Writing?
The lawsuits filed against AstraZeneca over whether the company failed to warn Seroquel users of the weight gain and diabetes risks associated with the drug throws up an interesting sidelight on the practice of "ghostwriting." Back in 2005, according to the British Medical Journal and the Guardian,...
Tags: AstraZeneca Plc., RxComms, Strategy, Management, Jim Edwards
Blog posts 2009-03-20
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement